Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avidity Biosciences Inc (NQ: RNA )

41.35 -0.83 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avidity Biosciences Inc

< Previous 1 2 3 4 5 6 Next >
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A High Point
The company is working on a treatment for a rare form of muscular dystrophy. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
A Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
Via Benzinga
Navigating 7 Analyst Ratings For Avidity Biosciences
Via Benzinga
Where Avidity Biosciences Stands With Analysts
Via Benzinga
A Closer Look at 5 Analyst Recommendations For Avidity Biosciences
Via Benzinga
2 Potentially High-Reward Growth Stocks to Buy Right Now
These two biotechnology stocks could be gearing up for a run. 
Via The Motley Fool
Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention. 
Via InvestorPlace
RNA Stock Earnings: Avidity Biosciences Misses EPS, Beats Revenue for Q1 2024
RNA stock results show that Avidity Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Via Benzinga
Topics ETFs
This Demand Zone In S&P 500 Needs To Hold
Find out the demand zone that the S&P 500 needs to hold to avoid a meaningful pullback. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising treatment for Myotonic dystrophy type 1. With strong management, proven... 
Via Benzinga
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Avidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease
New AOC 1001 data from Avidity Biosciences show reversal of disease progression in DM1 patients, using key endpoints in Phase 3 HARBOR trial. 
Via Benzinga
Top 2% Biotech Avidity Collapses Despite 'Positive' Results In Treating Muscular Dystrophy
The company is working on a treatment for myotonic dystrophy type 1, a form of muscular dystrophy. 
Via Investor's Business Daily
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... 
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Top 3 Health Care Stocks You May Want To Dump In Q1
As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
3 Highly Rated Biotech Stocks to Buy for 300% Gains
Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings. 
Via InvestorPlace
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering. 
Via Benzinga
FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM
FuelCell Energy stock is climbing higher on Tuesday as investors in FCEL celebrate the company signing a deal with IBM! 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts
Novocure layoffs are coming for 13% of the company's workers as it seeks to reduce its headcount by 200 people to reduce costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Lion Electric Layoffs 2023: What to Know About the Latest LEV Job Cuts
Lion Electric layoffs are coming for 150 of the electric bus company's employees as it seeks to reduce its headcount by 10%. 
Via InvestorPlace
Topics Electric Vehicles Workforce
Exposures Electric Vehicles Layoff
Why Is Avidity Biosciences (RNA) Stock Up 15% Today?
RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb. 
Via InvestorPlace
PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.